The FDA defied its own experts to approve a new prescription narcotic in a form almost certain to cause addiction and death from overdoses.
On October 26 the savvy investor’s website SeekingAlpha.com published the following remarkable comment about a new and highly addictive painkiller called Zohydro ER, which only the previous day had been approved for sale by the U.S. Food and Drug Administration despite consistent warnings – including from the FDA’s official advisory panel – that Z is potentially more addictive and dangerous than its sister opiate drug, the original and deadly OxyContin.
The full article can be read here:
Latest posts by Jeffrey Lynne (see all)
- DCF Advises Treatment Providers That ALL Recovery Residences Must Be Certified - June 5, 2018
- DOJ: Denying Services to Persons on MAT Violates ADA - May 14, 2018
- GAO Releases Report on Oversight of Recovery Residences - April 18, 2018